Patents by Inventor Dalong Lv

Dalong Lv has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11818440
    Abstract: A method for displaying a message on a smart television and a smart television are disclosed. The method includes: in response to an instruction for displaying a message received during a video call, determining a window type of the video call displayed on a television screen interface; determining whether a first window of the video call shields a predetermined message display position during display of the first window, based on the window type; in response to the first window shields the predetermined message display position during display, determining a current message display position that is not shielded by the first window on the television screen interface; and displaying a message alert box corresponding to the instruction at the current message display position, and the message alert box is not shielded by the first window.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: November 14, 2023
    Assignee: JUHAOKAN TECHNOLOGY CO., LTD.
    Inventors: Guangqiang Wang, Lingsheng Jiang, Dalong Lv, Yimin Li
  • Publication number: 20210400356
    Abstract: A method for displaying a message on a smart television and a smart television are disclosed. The method includes: in response to an instruction for displaying a message received during a video call, determining a window type of the video call displayed on a television screen interface; determining whether a first window of the video call shields a predetermined message display position during display of the first window, based on the window type; in response to the first window shields the predetermined message display position during display, determining a current message display position that is not shielded by the first window on the television screen interface; and displaying a message alert box corresponding to the instruction at the current message display position, and the message alert box is not shielded by the first window.
    Type: Application
    Filed: September 2, 2021
    Publication date: December 23, 2021
    Inventors: Guangqiang WANG, Lingsheng JIANG, Dalong LV, Yimin LI
  • Patent number: 9434949
    Abstract: The present invention discloses uses of the human ZFX gene and drugs associated therewith. Also disclosed are uses of the human ZFX gene in tumor treatment, tumor diagnosis, and drug preparation. Further disclosed are small interfering RNA (siRNA), and nucleic acid and lentivirus encoding the siRNA to the human ZFX gene and uses thereof. The siRNA and nucleic acid and lentivirus encoding the siRNA provided by the present invention can specifically inhibit the expression of human ZFX gene. Lentiviruses in particular can efficiently infect target cells, inhibit ZFX expression in target cells, and inhibit the growth of tumor cells, thus promote tumor apoptosis and have great significance in tumor treatment.
    Type: Grant
    Filed: August 16, 2011
    Date of Patent: September 6, 2016
    Assignee: SHANGHAI GENECHEM CO., LTD.
    Inventors: Yueqiong Cao, Dalong Lv, Xiangying Zhu, Haixiong Han, Honghua Qu, Yangsheng Jin
  • Publication number: 20140275219
    Abstract: The present invention discloses uses of the human ZFX gene and drugs associated therewith. Also disclosed are uses of the human ZFX gene in tumor treatment, tumor diagnosis, and drug preparation. Further disclosed are small interfering RNA (siRNA), and nucleic acid and lentivirus encoding the siRNA to the human ZFX gene and uses thereof. The siRNA and nucleic acid and lentivirus encoding the siRNA provided by the present invention can specifically inhibit the expression of human ZFX gene. Lentiviruses in particular can efficiently infect target cells, inhibit ZFX expression in target cells, and inhibit the growth of tumor cells, thus promote tumor apoptosis and have great significance in tumor treatment.
    Type: Application
    Filed: August 16, 2011
    Publication date: September 18, 2014
    Applicant: SHANGHAI GENECHEM CO., LTD.
    Inventors: Yueqiong Cao, Dalong Lv, Xiangying Zhu, Haixiong Han, Honghua Qu, Yangsheng Jin